GH
Grosvenor Holdings’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $40.2M | Hold |
1,037,256
| – | – | 7.85% | 5 |
|
|
2021
Q4 | $60.7M | Hold |
1,037,256
| – | – | 6.28% | 6 |
|
|
2021
Q3 | $61.5M | Sell |
1,037,256
-4,251
| -0.4% | -$252K | 7.53% | 3 |
|
|
2021
Q2 | $90.4M | Sell |
1,041,507
-82,069
| -7% | -$7.12M | 8.98% | 3 |
|
|
2021
Q1 | $92.6M | Sell |
1,123,576
-335,941
| -23% | -$27.7M | 6.81% | 5 |
|
|
2020
Q4 | $133M | Sell |
1,459,517
-876,233
| -38% | -$79.7M | 7.23% | 2 |
|
|
2020
Q3 | $93.4M | Hold |
2,335,750
| – | – | 6.88% | 3 |
|
|
2020
Q2 | $80.1M | Buy |
2,335,750
+128,500
| +6% | +$4.41M | 7.46% | 3 |
|
|
2020
Q1 | $49M | Sell |
2,207,250
-78,464
| -3% | -$1.74M | 5.57% | 11 |
|
|
2019
Q4 | $44.7M | Hold |
2,285,714
| – | – | 7.45% | 9 |
|
|
2019
Q3 | $35.5M | Buy |
+2,285,714
| New | +$35.5M | 6.41% | 8 |
|